Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1552943 No. of Pages: 62 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their treatment. The important side effects of TNF inhibitors include lymphomas, infections (especially reactivation of latent tuberculosis), congestive heart failure, demyelinating disease, a lupus-like syndrome, induction of auto-antibodies, injection site reactions, and systemic side effects.
This report aims to provide a comprehensive presentation of the global market for Tumor Necrosis Factor (TNF) Inhibitor Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Necrosis Factor (TNF) Inhibitor Drugs. This report contains market size and forecasts of Tumor Necrosis Factor (TNF) Inhibitor Drugs in global, including the following market information:
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Tumor Necrosis Factor (TNF) Inhibitor Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The market growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune diseases, and a significant rise in consumer awareness regarding Tumor Necrosis Factor (TNF).
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Necrosis Factor (TNF) Inhibitor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, by Type, 2022 (%)
Humira
Enbrel
Remicade
Simponi/Simponi Aria
Cimzia
Biosimilars
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Psoriasis
Psoriatic Arthritis
Crohn’s Disease
Ulcerative Colitis
Ankylosing Spondylitis
Juvenile Idiopathic Arthritis
Hidradenitis Suppurativa
Others
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
UCB S.A.
Novartis International AG
Pfizer, Inc.
Merck & co., Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor Necrosis Factor (TNF) Inhibitor Drugs, market overview.
Chapter 2: Global Tumor Necrosis Factor (TNF) Inhibitor Drugs market size in revenue.
Chapter 3: Detailed analysis of Tumor Necrosis Factor (TNF) Inhibitor Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor Necrosis Factor (TNF) Inhibitor Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Overall Market Size
2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size: 2022 VS 2029
2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market
3.2 Top Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies Ranked by Revenue
3.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Companies
3.4 Top 3 and Top 5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market
3.6.1 List of Global Tier 1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Markets, 2022 & 2029
4.1.2 Humira
4.1.3 Enbrel
4.1.4 Remicade
4.1.5 Simponi/Simponi Aria
4.1.6 Cimzia
4.1.7 Biosimilars
4.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
4.2.1 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2023
4.2.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2024-2029
4.2.3 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2022 & 2029
5.1.2 Rheumatoid Arthritis
5.1.3 Psoriasis
5.1.4 Psoriatic Arthritis
5.1.5 Crohn’s Disease
5.1.6 Ulcerative Colitis
5.1.7 Ankylosing Spondylitis
5.1.8 Juvenile Idiopathic Arthritis
5.1.9 Hidradenitis Suppurativa
5.1.10 Others
5.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
5.2.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2023
5.2.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2024-2029
5.2.3 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2022 & 2029
6.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
6.2.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2023
6.2.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2024-2029
6.2.3 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2029
6.3.2 US Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.3.3 Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.3.4 Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2029
6.4.2 Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4.3 France Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4.4 U.K. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4.5 Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4.6 Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.4.8 Benelux Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2029
6.5.2 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.5.3 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.5.4 South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.5.6 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2029
6.6.2 Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.6.3 Argentina Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2018-2029
6.7.2 Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.7.3 Israel Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
6.7.5 UAE Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2018-2029
7 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.1.4 AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 Amgen Inc.
7.2.1 Amgen Inc. Company Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.2.4 Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.2.5 Amgen Inc. Key News & Latest Developments
7.3 Johnson & Johnson Services, Inc.
7.3.1 Johnson & Johnson Services, Inc. Company Summary
7.3.2 Johnson & Johnson Services, Inc. Business Overview
7.3.3 Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.3.4 Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Services, Inc. Key News & Latest Developments
7.4 UCB S.A.
7.4.1 UCB S.A. Company Summary
7.4.2 UCB S.A. Business Overview
7.4.3 UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.4.4 UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.4.5 UCB S.A. Key News & Latest Developments
7.5 Novartis International AG
7.5.1 Novartis International AG Company Summary
7.5.2 Novartis International AG Business Overview
7.5.3 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.5.4 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis International AG Key News & Latest Developments
7.6 Pfizer, Inc.
7.6.1 Pfizer, Inc. Company Summary
7.6.2 Pfizer, Inc. Business Overview
7.6.3 Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.6.4 Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.6.5 Pfizer, Inc. Key News & Latest Developments
7.7 Merck & co., Inc.
7.7.1 Merck & co., Inc. Company Summary
7.7.2 Merck & co., Inc. Business Overview
7.7.3 Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.7.4 Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2018-2023)
7.7.5 Merck & co., Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com